How the Vaccine News Might Change Bitcoin’s Attractiveness to Institutions
While the economy has been on thin ice, no asset has benefitted more from the post-pandemic “new normal”
Read More
Vaccine
Vaccine News: The Biggest Macro Event Since March
According to the bright minds of FinTwit, the biggest event isn’t the U.S. presidential election but today’s Pfizer vaccine update.Our main discussion: The stock market soars on promising Pfizer COVID-19 vaccine trials. The S&P 500 and DJIA hit new all-time highs after Pfizer announced its experimental vaccine had prevented COVID-19 in
Read More
Pfizer COVID-19 Vaccine Efficacy Spurs Market Surge
Following the positive news about the Pfizer COVID-19 vaccine efficacy, the stock market has responded with big jumps.The first interim COVID-19 vaccine analysis result from the duo of Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) is out and the COVID-19 vaccine candidate shows about 90% efficacy. Per the
Read More
Markets Spike as Coronavirus Vaccine Trial Shows 90% Success Rate
Bitcoin and U.S. stock futures shot up on Monday after Pfizer announced positive results from a trial of its coronavirus vaccine. Source
Read More
First Mover: What’s Next for Bitcoin as Wall Street Gets Vaccine Booster
Bitcoin was higher for a second day, staying in a range between roughly $15,200 and $15,600, as news of progress in developing a coronavirus vaccine appeared to touch off a rally in U.S. stocks. With the outcome of last week’s U.S. presidential election now mostly settled, crypto analysts turned to other market factors,
Read More
Bitcoin Falls on Positive Coronavirus Vaccine Results; Risks Ahead?
Bitcoin’s second attempt to close above $16,000 hit a wall on Monday as traders assessed the latest progress
Read More
AstraZeneca to Release Trial Data for Covid-19 Vaccine by Year End
Currently, AstraZeneca vaccine trials are in the late-stages, involving about 23,000 participants. The participants span across the UK, U.S., South Africa, and Brazil.British-Swedish pharmaceutical company AstraZeneca Plc (LON: AZN) hopes to release its vaccine data by the end of the year. The drugmaker announced the development as it reports a
Read More
COVID-19 Vaccine Volunteer in AstraZeneca Trial Dies, AZN Stock Down
It is unclear whether the volunteer took the vaccine dose or was in a placebo group. AstraZeneca has not provided much information but said they followed all required review processes.hasSoon after resuming the COVID-19 vaccine trial at almost all sites, AstraZeneca plc (NASDAQ: AZN) has faced another challenge. On Wednesday,
Read More
BNTX Shares Rise 10%, EU Begins Review of BioNTech-Pfizer Vaccine
The start of the review process of the BioNTech-Pfizer vaccine has triggered investors to bet more on BNTX stock.The European Union’s European Medicines Agency (EMA) has commenced the review of BNT162b2, the BioNTech-Pfizer COVID-19 vaccine candidate being developed by the duo of BioNTech SE (NASDAQ: BNTX) and Pfizer Inc (NYSE:
Read More
AZN Stock Slightly Down, AstraZeneca Resumes Vaccine Trials in Japan
AstraZeneca’s clinical trials for the vaccine were halted in July after one of the participants complained of neurological disorder.Foremost COVID-19 vaccine pharmaceutical firm AstraZeneca Plc (LON: AZN) has disclosed that it has resumed its mid-late stage COVID-19 Vaccine trial in Japan, following the earlier global suspension of the process. As
Read More